Cera delivers home healthcare at scale by pairing a large workforce of carers and nurses with an AI platform that turns everyday care visits into predictive health data. Carers log detailed observations through Cera's app during home visits, and the company's AI analyzes this stream of data to flag early signs of deterioration, predicting risks such as falls and hospitalizations days in advance so interventions can happen sooner.
The model aims to shift care out of expensive hospital settings and into the home, both improving patient outcomes and reducing system costs. Cera reports that its predictive technology helps prevent a significant share of hospitalizations among the patients it serves, and that it delivers a large and growing volume of home care visits across the UK.
Founded in 2016 and headquartered in London, UK, Cera was founded by Dr. Ben Maruthappu, a physician who launched the company after experiencing the difficulty of arranging home care for a family member. It has grown into one of Europe's largest digital health companies.
Cera raised a $150 million funding round to expand its AI platform, broaden its services, and support operational growth. Its investors over time have included Kairos HQ, Yabeo, Guinness Asset Management, and others backing its mission to scale technology-enabled home care.
Cera positions itself as a preventive, AI-driven alternative to reactive hospital-centric care, using data from millions of care interactions to anticipate health needs.